R
ISSUER//CIK 0001709401
Rubius Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A8.2 KBRubius Therapeutics, Inc.Apr 10, 9:37 AM ET·0000315066-23-002230
- 8-K198.4 KBRubius Therapeutics, Inc.Apr 6, 5:11 PM ET·0001104659-23-042792
- 8-K204.8 KBRubius Therapeutics, Inc.Mar 3, 4:14 PM ET·0001104659-23-028428
- SC 13G/A10.8 KBRubius Therapeutics, Inc.Mar 3, 11:28 AM ET·0001088875-23-000072
- 10-K7.6 MBRubius Therapeutics, Inc.Feb 27, 7:36 AM ET·0001709401-23-000005
- 8-K238.9 KBRubius Therapeutics, Inc.Feb 22, 6:41 AM ET·0001104659-23-024013
- SC 13G/A160.7 KBRubius Therapeutics, Inc.Feb 14, 1:00 PM ET·0001193125-23-038310
- SC 13G/A8.3 KBRubius Therapeutics, Inc.Feb 9, 12:31 PM ET·0000315066-23-002039
- 8-K252.4 KBRubius Therapeutics, Inc.Feb 6, 4:05 PM ET·0001104659-23-011161
- SC 13G/A11.2 KBRubius Therapeutics, Inc.Jan 20, 7:32 AM ET·0001088875-23-000033
Insiders
10- AFEYAN NOUBARDirector, 10% Owner
- Appelhans DannielleChief Operating Officer
- CAGNONI PABLO JDirector, Chief Executive Officer
- Carmona JoseChief Financial Officer
- CARPENTER CHRISTOPHER L.Chief Medical Officer
- Coughlin Christina M.Chief Medical Officer
- Cuss Francis MDirector
- Epstein David RDirector
- Flagship VentureLabs IV, LLC10% Owner
- Flagship Ventures Fund IV General Partner LLCDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035
mailing
C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035